209 related articles for article (PubMed ID: 32083992)
1. Clinical and Genetic Risk Prediction of Cognitive Impairment After Blood or Marrow Transplantation for Hematologic Malignancy.
Sharafeldin N; Richman J; Bosworth A; Chen Y; Singh P; Patel SK; Wang X; Francisco L; Forman SJ; Wong FL; Bhatia S
J Clin Oncol; 2020 Apr; 38(12):1312-1321. PubMed ID: 32083992
[TBL] [Abstract][Full Text] [Related]
2. Self-endorsed cognitive problems versus objectively assessed cognitive impairment in blood or bone marrow transplantation recipients: A longitudinal study.
Murdaugh DL; Bosworth A; Patel SK; Sharafeldin N; Chen Y; Francisco L; Forman SJ; Wong FL; Bhatia S
Cancer; 2020 May; 126(10):2174-2182. PubMed ID: 32097508
[TBL] [Abstract][Full Text] [Related]
3. Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study Report.
McDonald AM; Chen Y; Wu J; Hageman L; Francisco L; Kung M; Wong FL; Ness E; Landier W; Battles K; Salzman D; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
J Clin Oncol; 2020 Sep; 38(25):2872-2882. PubMed ID: 32673169
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood.
Holmqvist AS; Chen Y; Wu J; Battles K; Bhatia R; Francisco L; Hageman L; Kung M; Ness E; Parman M; Salzman D; Wadhwa A; Winther JF; Rosenthal J; Forman SJ; Weisdorf DJ; Armenian SH; Arora M; Bhatia S
JAMA Oncol; 2018 Dec; 4(12):e182453. PubMed ID: 30054602
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide variants and polygenic risk scores for cognitive impairment following blood or marrow transplantation.
Sharafeldin N; Zhang J; Singh P; Bosworth A; Chen Y; Patel SK; Wang X; Francisco L; Forman SJ; Wong FL; Ojesina AI; Bhatia S
Bone Marrow Transplant; 2022 Jun; 57(6):925-933. PubMed ID: 35379913
[TBL] [Abstract][Full Text] [Related]
6. Cognitive Functioning After Hematopoietic Cell Transplantation for Hematologic Malignancy: Results From a Prospective Longitudinal Study.
Sharafeldin N; Bosworth A; Patel SK; Chen Y; Morse E; Mather M; Sun C; Francisco L; Forman SJ; Wong FL; Bhatia S
J Clin Oncol; 2018 Feb; 36(5):463-475. PubMed ID: 29252122
[TBL] [Abstract][Full Text] [Related]
7. Pain in older survivors of hematologic malignancies after blood or marrow transplantation: A BMTSS report.
Farrukh N; Hageman L; Chen Y; Wu J; Ness E; Kung M; Francisco L; Parman M; Landier W; Arora M; Armenian S; Bhatia S; Williams GR
Cancer; 2020 Jan; 126(9):2003-2012. PubMed ID: 32022263
[TBL] [Abstract][Full Text] [Related]
8. CD31 mismatching affects marrow transplantation outcome.
Grumet FC; Hiraki DD; Brown BWM ; Zehnder JL; Zacks ES; Draksharapu A; Parnes J; Negrin RS
Biol Blood Marrow Transplant; 2001; 7(9):503-12. PubMed ID: 11669217
[TBL] [Abstract][Full Text] [Related]
9. Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study.
Kashyap A; Kandeel F; Yamauchi D; Palmer JM; Niland JC; Molina A; Fung H; Bhatia R; Krishnan A; Nademanee A; O'Donnell MR; Parker P; Rodriguez R; Snyder D; Spielberger R; Stein A; Nadler J; Forman SJ
Biol Blood Marrow Transplant; 2000; 6(3A):344-51. PubMed ID: 10905772
[TBL] [Abstract][Full Text] [Related]
10. Deformation Analysis of Myocardial Layers Detects Early Cardiac Dysfunction after Chemotherapy in Bone Marrow Transplantation Patients: A Continuous and Additive Cardiotoxicity Process.
Paraskevaidis IA; Makavos G; Tsirigotis P; Psarogiannakopoulos P; Parissis J; Gkirkas K; Pessach I; Ikonomidis I
J Am Soc Echocardiogr; 2017 Nov; 30(11):1091-1102. PubMed ID: 28864152
[TBL] [Abstract][Full Text] [Related]
11. Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
Vasconcelles MJ; Bernardo MV; King C; Weller EA; Antin JH
Biol Blood Marrow Transplant; 2000; 6(1):35-43. PubMed ID: 10707997
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic Bone Marrow Transplantation versus Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies in Children: A Systematic Review and Meta-Analysis.
Shimosato Y; Tanoshima R; Tsujimoto SI; Takeuchi M; Shiba N; Kobayashi T; Ito S
Biol Blood Marrow Transplant; 2020 Jan; 26(1):88-93. PubMed ID: 31394270
[TBL] [Abstract][Full Text] [Related]
13. Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant.
Karaesmen E; Rizvi AA; Preus LM; McCarthy PL; Pasquini MC; Onel K; Zhu X; Spellman S; Haiman CA; Stram DO; Pooler L; Sheng X; Zhu Q; Yan L; Liu Q; Hu Q; Webb A; Brock G; Clay-Gilmour AI; Battaglia S; Tritchler D; Liu S; Hahn T; Sucheston-Campbell LE
Blood; 2017 Sep; 130(13):1585-1596. PubMed ID: 28811306
[TBL] [Abstract][Full Text] [Related]
14. Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor Study.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Battles K; Kung M; Ness E; Parman M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2261-2266. PubMed ID: 31278995
[TBL] [Abstract][Full Text] [Related]
15. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.
Dey BR; McAfee S; Colby C; Sackstein R; Saidman S; Tarbell N; Sachs DH; Sykes M; Spitzer TR
Biol Blood Marrow Transplant; 2003 May; 9(5):320-9. PubMed ID: 12766882
[TBL] [Abstract][Full Text] [Related]
16. Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting?
Rizzo JD; Vogelsang GB; Krumm S; Frink B; Mock V; Bass EB
J Clin Oncol; 1999 Sep; 17(9):2811-8. PubMed ID: 10561357
[TBL] [Abstract][Full Text] [Related]
17. Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation.
Harder H; Cornelissen JJ; Van Gool AR; Duivenvoorden HJ; Eijkenboom WM; van den Bent MJ
Cancer; 2002 Jul; 95(1):183-92. PubMed ID: 12115332
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults.
Kasamon YL; Bolaños-Meade J; Prince GT; Tsai HL; McCurdy SR; Kanakry JA; Rosner GL; Brodsky RA; Perica K; Smith BD; Gladstone DE; Swinnen LJ; Showel MM; Matsui WH; Huff CA; Borrello I; Pratz KW; McDevitt MA; Gojo I; Dezern AE; Shanbhag S; Levis MJ; Luznik L; Ambinder RF; Fuchs EJ; Jones RJ
J Clin Oncol; 2015 Oct; 33(28):3152-61. PubMed ID: 26261255
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Cognitive Impairment and Association With Survival Among Older Patients With Hematologic Cancers.
Hshieh TT; Jung WF; Grande LJ; Chen J; Stone RM; Soiffer RJ; Driver JA; Abel GA
JAMA Oncol; 2018 May; 4(5):686-693. PubMed ID: 29494732
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor Study.
Arora M; Chen Y; Wu J; Hageman L; Ness E; Kung M; Francisco L; Bosworth A; Weisdorf DJ; Forman SJ; Landier W; Pamukçuoğlu M; Armenian SH; Wong FL; Bhatia S
Cancer; 2021 Mar; 127(5):794-800. PubMed ID: 33206383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
